What's breaking now, across thousands of outlets.
(MedPage Today) -- Cardiologists Ronald Karlsberg, MD, and Venkatesh Murthy, MD, PhD, are among the new appointees to the U.S. Preventive Services Task Force (USPSTF). Inspired by the search for Nancy Guthrie, scientists find it technically feasible...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Celldex said its experimental treatment barzolvolimab hit its primary endpoint in two Phase 3 trials, even as the readout raised safety concerns on two life-threatening cases of allergic reaction…
The Drugs Controller General of India advises that all non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics must be sold and distributed only on the prescription of a registered medical…
Plus news about Boehringer, Envisagenics, Ionis, Otsuka, Merck, Lexeo and Mantle. Amgen gets a win from Horizon buyout: Amgen said dazodalibep, a CD40 ligand antagonist, succeeded in a Phase ...
Long-term research finds most children recovered from the effects of the pandemic.
Type 1 diabetes isn't an overnight attack against the body's ability to make insulin. It can be a sustained campaign over years that relentlessly targets insulin-producing cells in the pancreas.
Though barzolvolimab displayed what one analyst described as the best efficacy results to date against chronic skin hives, treatment was also associated with two life-threatening anaphylaxis cases.
